Previous close | 11,006.00 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 2,131,802 |
Market cap | 172.07B |
Beta (5Y monthly) | 0.17 |
PE ratio (TTM) | 34.27 |
EPS (TTM) | 3.24 |
Earnings date | 09 Nov 2023 |
Forward dividend & yield | 2.35 (2.11%) |
Ex-dividend date | 10 Aug 2023 |
1y target est | 128.92 |
There’s value in the pharmaceutical sector, but these two FTSE 100 stocks have quite different characteristics to consider. The post Which is the best value stock now: AstraZeneca or GSK? appeared first on The Motley Fool UK.
Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings potential.
In the latest trading session, Astrazeneca (AZN) closed at $67.42, marking a -0.77% move from the previous day.